midazolam has been researched along with Metabolic Syndrome in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The paper concerns the anesthetic aspects of safe conscious sedation and dental treatment of patients with metabolic syndrome." | 1.37 | [The improvement of safe sedation and dental treatment in patients with metabolic syndrome]. ( Dobrodeev, AS; Rabinovich, SA; Remez, GA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobrodeev, AS | 1 |
| Rabinovich, SA | 1 |
| Remez, GA | 1 |
1 other study available for midazolam and Metabolic Syndrome
| Article | Year |
|---|---|
[The improvement of safe sedation and dental treatment in patients with metabolic syndrome].
Topics: Adult; Aged; Anesthesia, Dental; Anesthesia, Intravenous; Anesthetics, Intravenous; Conscious Sedati | 2011 |